RGS proteins regulate G protein-mediated signalling pathways through direct interaction with the Ga subunits and facilitation of GTP hydrolysis. An RGS subfamily consisting of RGS 6, 7, 9, and 11 also interacts with the G protein b subunit Gb 5 via a characteristic Gg-like domain. Thus far, these complexes were found only in neurons, with RGS7 being the most widely distributed in the brain. Here we con®rm the expression of RGS7 in spinal neurons and show as a novel ®nding that following an experimental spinal cord injury in rats, expression of RGS7 is induced in a subpopulation of other cells. Immuno¯uorescent confocal microscopy using a series of cell speci®c antibodies identi®ed these RGS7 positive cells as activated microglia and/or invading peripheral macrophages. To rule out interference from the adjacent neurons and con®rm the presence of RGS7-Gb 5 complex in in¯ammatory cells, we performed immunocytochemistry, RT-PCR, Western blot, and immunoprecipitation using microglial (BV2) and peripheral macrophage (RAW) cell lines. Expression of RGS7 mRNA and protein are nearly undetectable in non-stimulated BV2 and RAW cells, but remarkably increased after stimulation with LPS or TNF-a In addition, RGS7-positive cells were also found in the perinodular rim in the rat spleen. Our ®ndings show that RGS7-Gb 5 complex is expressed in immunocompetent cells such as resident microglia and peripheral macrophages following spinal cord injury. This expression might contribute to the post-traumatic in¯ammatory responses in the central nervous system.
Introduction
G-protein coupled receptors are the largest family of cell-surface receptors and mediate numerous functions essential for maintaining homeostasis of the organism. Heterotrimeric G proteins consist of an a, b, and g subunit. The Ga subunit binds guanine diphosphate (GDP). Receptor-mediated activation of the Ga subunit facilitates the release of bound GDP allowing guanine-triphosphate (GTP) to bind. This causes the Ga subunit to dissociate from the tightly associated bg-complex (Birnbaumer, 1992) . The active Ga-GTP complex as well as free bg, modulate effector enzymes and ion channels, altering the intracellular concentration of second messengers. This activation lasts until hydrolysis of GTP occurs.
The rate of GTP hydrolysis is controlled by a family of accessory proteins called regulators of G protein signalling (RGS) that act as GTPase activating proteins (GAP) for the Gb subunits (Berman et al., 1996; Hunt et al., 1996; . The RGS family consists of approximately 30 members and share a conserved RGS box, a 120-amino acid domain which is responsible for the binding of Ga and GTP hydrolysis. RGS7 is a member of the neuron-speci®c RGS subfamily (RGS 6, 7, 9, 11) . This subfamily is characterized by the presence of two additional structural domains. The ®rst is the Gglike (GGL) domain which interacts with Gb 5 (Snow et al, 1998; Levay et al., 1999) . The second is the DEP domain which is also found in a number of signalling molecules, but its function is yet unknown (Ponting & Bork, 1996) . The structure and functional activity of Gb 5 is markedly different from the other four Gb 1±4 isoforms. Gb 5 was previously only detected in mammalian brain and retina (Watson et al., 1994; Cabrera et al., 1998; Makino et al., 1999; Witherow et al. 2000; Zhang et al. 2001) . In vitro, Gb 5 associates Gg subunits, but in vivo it is only found in a tightly associated complex with GGL-containing RGSs, with dimerization being necessary to stabilize both Gb 5 and RGS (Cabrera et al., 1998; Chen et al., 2000; Witherow et al., 2000; Zhang & Simonds 2000; Chase et al., 2001; Zhang et al., 2001) .
Spinal cord injury (SCI) initiates a robust immune response characterized in part by the synthesis of cytokines and chemokines as well as the coordinated in®ltration of peripheral leukocytes (Acarin et al, 2000; Schwab & Bartholdi, 1996; Bartholdi & Schwab, 1997; Klusman & Schwab, 1997; Popovich et al, 1997; Bethea et al., 1998; Bethea et al., 1999; Hayashi et al., 2000) . SCI-induced in¯ammation may result in a further deterioration of functional outcome due to the development of scar tissue and necrosis or apoptosis of neurons and oligodendrocytes. However, the exact mechanism, and consequences of a SCI-induced in¯ammatory response with activation of central nervous system (CNS) resident microglia and recruitment of bloodborn in¯ammatory cells is not fully understood at this time.
Previous studies have demonstrated that RGS7 may play a role in tumour necrosis factor-a (TNF-a)-mediated immune responses within the CNS . TNF-a prevents proteasomedependent degradation of RGS7 via a stress-activated protein kinase p38-mediated mechanism .
In this study, we investigated if SCI alters RGS7 expression in the spinal cord. We demonstrate that RGS7 and Gb 5 are not only expressed in neurons but following injury this expression also occurs in microglia/macrophages. These data suggest that RGS7 may be an important mediator of SCI-induced activation of the post-traumatic in¯ammatory cascade.
Materials and methods

Experimental paradigm
Adult female Fischer rats underwent moderate contusive SCI as previously described (Bethea et al., 1998; Bethea et al., 1999) . Spinal cords were harvested 1, 3, 7, and 14 days after surgery. At each time point, six animals were killed; the normal non-injured control group consisted of six animals. Spinal cords were dissected and tissues prepared for histological, immunohistochemical, and quantitative protein studies.
Surgery
All surgical procedures were approved by the Department of Veterinary Resources of the University of Miami. The rats were anaesthetized with 1% halothane (in 60 : 40 oxygen : nitrogen). As antibiotic prophylaxis penicillin G was given. A laminectomy was performed on the 8th thoracic vertebra (T8) under a stereomicroscope. A moderate spinal cord contusion was performed using the NYU impactor weight-drop device (Basso et al., 1996; Bethea et al., 1998; Bethea et al, 1999) . The vertebral column was stabilized using clamps on T7 and T9 spinal processes, and a 10-g weight rod was dropped from 12.5 mm height onto the exposed dorsal aspect of the spinal cord. The rod was immediately removed, and the muscles and the skin were closed. SCI data (e.g. impact velocity and compression depth) were recorded and analyzed (NYU spinal cord contusion system, impactor software version 7.0) as described previously (Basso et al., 1996) . The analysis of the impact data showed a successful contusion in all cases.
Immunohistochemistry
For immunohistochemical studies, the rats were euthanized with an overdose of rat cocktail (ketamine 42.8 mg/mL, xylazine 8.6 mg/mL, acepromazine 1.4 mg/mL) and pericardially perfused with a 0.1 M phosphate buffer (PB) solution containing heparin (50 000 IU/L), followed by ice-cold 4% paraformaldehyde in 0.1 M PB, pH 7.4. The spinal cords and spleens (control tissue for immunocompetent cells) were dissected and post-®xed overnight in the same ®xative. All tissue samples were cryo-preserved with buffered 25% sucrose. Spinal cords were divided into cervical, thoracic, and lumbar segments and stored at 4°C until further processing. Serial freeoating sagittal sections were cut frozen on the sliding microtome at 40 mm thickness throughout the thoracic, cervical, and lumbar spinal cord. The sections were stored at ±20°in cryo-protective solution (30% sucrose and 30% ethylene glycol in 0.1 M PB) until further processing.
Puri®ed polyclonal rabbit anti-RGS7 and Gb 5 antibodies were raised against speci®c peptides, as previously described (Cabrera et al., 1998; Levay et al., 1999; Witherow et al., 2000) . Antibody speci®city was tested by peptide blocking experiments. As a negative control, the primary antibody was omitted.
To detect the expression of RGS7 protein in the rat spinal cord, serial sections were stained with the anti-RGS7 antibody. Endogenous peroxidases were quenched with 0.3% hydrogen peroxide for 30 min and nonspeci®c antigens were blocked with a mixture of 5% normal goat serum and 2% normal rat serum. Permeabilization of the cell membranes was achieved by adding 0.4% Triton X-100 (TX) (Sigma Chemicals, St Louis, MO) to preincubation and incubation solutions. All solutions were made in saline PB (PBS). After preincubation, sections were incubated with anit-RGS7 antibody (1 : 5000) overnight at 4°C. After several washes in PBS containing 0.4% TX, tissue sections were incubated for 1.5 h with secondary antibodies (biotinylated goat anti-rabbit IgG) 1 : 200, followed by a series of rinses and 1.5 h incubation with Avidin Biotin Complex (ABC Elite) 1 : 100 (biotinylated IgG and Vectastatin ABC Elite standard kit, Vector Laboratories, Burlingame, CA). Reaction was developed with nickel intensi®ed DAB (0.05% of 3,3-diaminobenzidine (DAB, Sigma Chemicals), 2.5% nickel ammonium sulphate in 0.05 M acetate, 0.002 M imidazole buffer at pH 7.2) and 0.001% hydrogen peroxide.
Immuno¯uorescence
To demonstrate the localization of the RGS7 protein in a variety of cell types in non-injured and injured spinal cord, alternative serial sections were double labelled with anti-RGS7 and various neuronal, glial, and immune cell markers. All sections were quenched in 2% sodium para-periodate (Sigma Chemicals) to reduce nonspeci®c background and enhance¯uorescent signal, blocked with preimmune serum and permeabilized with TX (PBS + 5% normal goat serum + 2% normal rat serum + 0.4% TX). Sections were incubated with the anti-RGS7 antibody 1 : 100 overnight at 4°C. To demonstrate the RGS7-Gb 5 complex in cell cultures, anti-Gb 5 antibodies were used at 1 : 200 (the sensitivity of these antibodies was reduced in tissue, therefore we used it only for in vitro immunocytochemistry). Following several rinses in PB, sections were incubated with goat anti-rabbit IgG conjugated to Alexa 488 (green) (Molecular Probes, Eugene, Oregon). After ®rst antibody labelling, tissue was divided into series labelled for neuronal, glial, and immune cell markers. Neurons were stained with mouse monoclonal antineuronal nuclei (NeuN) 1 : 200 (Chemicon International, Temecula, CA). To visualize the cytoskeleton of neurons, mouse monoclonal anti-btubulin III (TuJ1) 1 : 300 (Sigma Chemicals) and anti-neuro®lament M (145 kDa) 1 : 200 (Chemicon International). Astrocytes were labelled with a mouse monoclonal anti-glial ®brillary acid protein (GFAP) 1 : 400 (Chemicon International), oligodendrocytes and schwann cells with mouse monoclonal anti-CNPase antibody 1 : 400 (Sigma Chemicals) and RIP 1 : 40 (hybridoma developed by S. Hock®eld, obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA). To demonstrate the presence of microglia and peripheral phagocytic macrophages, the following antibodies were used: mouse monoclonal anti-rat ARU 0151 1 : 400 against cytoplasmatic ED-I (Biosource International, Camarillo, CA) and mouse monoclonal anti-rat OX-42 1 : 400 against CD 11 membrane protein Cd3 receptor (PharMingen, San Diego, CA). Secondary antibodies were conjugated with Alexa 594 (red).
The slides were studied under Zeiss Axioplan 2 Fluorescence and Zeiss confocal LSM 510 microscopes (Carl Zeiss, Thornwood, NY). The image assembly (Adobe Photoshop) and illustration (Adobe Illustrator) software programs were obtained from Adobe Systems, Inc., San Jose CA. Confocal scanning settings were not changed nor was the staining intensity enhanced by subsequent picture processing for each individual antibody.
Analysis of RGS7 expression in spinal cord
For Western blot studies, animals were anaesthetized in a chamber with halothane and decapitated. The cervical, thoracic, and lumbar spinal cords were removed by hydrostatic pressure and the cords were frozen instantly on dry ice. All samples were stored at ±80°C until further processing.
The tissue was homogenized in the buffer containing 20 mM Tris pH 7.5, 100 mM NaCl, 1 mM DTT and 1 mM PMSF at the total protein concentration of 5 mg/mL then 20 mL were mixed with 20 mL of 2Q SDS PAGE sample buffer resolved on a 10% SDS gel, transferred to a nitrocellulose ®lter, probed with RGS7 antibody and developed using enhanced chemoluminiscent as described previously (Witherow et al., 2000) . The ®lm was scanned and analyzed by Scion Image (Imagequant Software). For quantitative comparison of RGS7 levels in different regions after injury or in control, the samples were subjected to serial dilutions in order to achieve a linear dependence of ECL signals from the amount of protein loaded on the gel; each dilution was analyzed in duplicate. All Western blots were normalized to b-actin.
Cell culture
The mouse peripheral macrophages cell line RAW 264.7 and a mouse microglia BV2 cell line were maintained in high glucose Dulbecco's modi®ed Eagle medium containing 10% fetal bovine serum, 100 mg/ mL Penicillin G and 100 mg/mL Streptomycin (Gibco BRL, Grand Island, NY) at 37°C and 5% CO 2 . For¯uorescent staining the cells were seeded on 8-well plastic chamber slides. For Western blot and polymerase chain reaction (PCR) cells were seeded (cell density: 500 000 per well) into 6-well dishes. RAW and BV2 cells were stimulated with 10 ng/mL TNF-a (R & D Systems, Minneapolis, MN) and 1 mg/mL lipopolysaccahride (LPS) (Sigma Chemicals) for 1, 6, 12, 24, and 48 h.
As rat sympathetic PC12 pheochromocytoma cells are known to express RGS7 and Gb 5 (Zhang et al., 2001) , this cell line was used as a positive control for immunocytochemistry. As an additional unbiased control for immunocytochemistry, human embryonic kidney (HEK) 293 T cells were transfected with RGS7 cDNA using a standard Lipofectamine protocol described previously (Witherow et al., 2000) .
Detection of RGS7 mRNA by RT-PCR in RAW cells
The expression of RGS7 mRNA in naõ Ève and LPS or TNF-a stimulated RAW cells was con®rmed by reverse transcription and polymerase chain reaction (RT-PCR). RNA was isolated with Ultraspect TM (Biotecx Laboratories Inc., Houston TX) and treated with DNAase before RT. For the standard RT reaction 2 ng of RNA was used.
Primers set for sense (5¢-CCATGGCTACTTCTTTCCCA-3¢) and antisense (5¢-CTAGCCTTGCCTTGTTTTGC-3¢) (AlphaDNA, Montreal, Canada) were used. PCR conditions were as follows: 94°C for 30 s, 55°C for 45 s, and 72°C for 60 s for 35 cycles.
Immunoprecipitation
Immunoprecipitation with RGS7 antibody was carried out using Protein A Sepharose as described in detail previously (Witherow et al., 2000) . RAW cells were stimulated with TNF-a (25 ng/mL) Semi-quantitative evaluation of the time-course of the RGS7 expression shows an increased intensity of the immunohistochemical DAB staining 1, 3, and 7 days after SCI (Fig. 1A±E) . Criteria for the blinded evaluation were as follows. (+) Baseline immunoreactivity with staining of the grey and white matter. The shape of neurons in the grey can be differentiated. The white matter staining is characterized by a slight staining of the ®bers mesh-work.
(++) Increased intensity of the DAB staining of the neurons and also of the intercellular space in the grey matter. In the white matter, the majority of ®bers stain distinctively with DAB, however, axonal end bulbs may not be seen.
(+++) Appearance of RGS7 strongly positive cells in the grey and white matter adjacent to the lesion. The staining intensity of these cells is much higher compared to the DAB staining of neurons in the grey matter in uninjured and injured tissue. Intensively DAB positive axonal end bulbs are in the white matter. 24 h before collection. RAW cells were homogenized in PBS containing protease inhibitor mixture (Roche Molecular Biochemicals, Indianapolis, IN). The lysates were spun in a tabletop centrifuge at 4°C for 20 min. The pellet was resuspended in PBS containing 1% Triton-X 100 for 30 min. The cleared lysate (500 mL) was mixed with the antibodies and 40 mL of Protein beads overnight.
The beads were washed with 20 mM Tris-HCl pH 7.4, 50 mM NaCl, 1 mM EDTA, and 1 mM EGTA and then eluted with 1% SDS. Samples were analyzed by Western blotting using Gb 5 antibody.
Results
RGS7 expression following spinal cord injury
The grey and white matter of the uninjured spinal cord stained with the anti-RGS7 antibody. In the grey matter, cells with a morphology resembling motoneurons were immunopositive for RGS7. Typically, the staining pattern of these cells had a granular cytoplasmatic appearance. In the white matter, sharply de®ned neuronal ®bers were RGS7 positive, few of these white matter ®bers were running perpendicular entering the grey matter (Fig. 1A) .
In the injured tissue, there was a marked increase in RGS7 expression in some cells. These cells were seen only in the injured tissue and were mainly located close to the lesion epicentre. Further, in the injured tissue several of the white matter ®bers had axonal end bulbs (Fig. 1B±F) . Semi-quantitative evaluation of RGS7 immunoreactivity revealed detectable RGS7 expression 1 day post-injury, with levels peaking between 3 and 7 days after SCI (Table 1) .
Western blotting was performed to quantitatively evaluate RGS7 protein expression following SCI. The overall level of RGS7 in the homogenized tissue, as revealed by quantitative Western blot, did not change (Fig. 2) . Gb 5 levels in the same spinal cord segments also remained unchanged after injury (data not shown). Because progressive neuronal cell death occurs in the grey matter, the constant expression of RGS7 is likely due to either in®ltrating cells from the periphery, induced expression in CNS cells not constitutively expressing RGS7, or a combination of both.
Cell type determination of RGS7 expression
Neurons are RGS7 positive in controls and SCI rats To con®rm that neurons express RGS7, we used double-labelling with the anti-RGS7 antibody and antibodies against neuronal markers (NeuN, antineuro®lament, and anti-b-tubulin III (TuJ1)). Neuronal expression of RGS7 was con®rmed with all three neuronal markers. The grey matter stained with a distinct granular meshwork-like pattern sparing the nuclei of motoneurons (Fig. 3A) .
Using the laser confocal microscopy, RGS7 positive cells localized with NeuN positive neurons within the grey matter. Analysis of 1mm thick optical sections, revealed that the granular RGS7 staining was mainly colocalized on the surface of the neurons (Fig. 3B, D and E) and near the perinuclear membrane, but less intense within the cytoplasm and not in the nucleus. Double staining for neuro®laments and RGS7 showed that the RGS7 positive granular structures followed the nerve ®bers. As in the DAB staining, enlarged antineuro®lament positive axonal end bulbs were seen in the injured white matter, which colocalized with RGS7 ( Fig. 3F and G) . Confocal microscopy of anti-b-tubulin III (Tu J1) and RGS7 double-labelled tissue revealed that the RGS7 positive granula colocalized with the neuronal b-tubulin positive structures in uninjured and injured tissues. In the white matter, the more linear staining pattern could be seen where RGS7 positive granules surrounded b-tubulin positive ®bers. In the grey matter, clusters of RGS7 positive meshwork in the extracellular space were seen mainly in the injured tissue, possibly representing granules in receptor or dendrites. The anti-b-tubulin III (TuJ1) staining con®rmed the ®ndings of the NeuN staining showing the granular RGS7 pattern mainly on the surface of the cell bodies and along the nerve ®bers tracts.
Astrocytes and oligodendrocytes do not colocalize with RGS7
Astrocytes were stained with GFAP; oligodendrocytes were labelled with CNPase and RIP. RGS7 positive cells did not colocalize with astrocytes or with oligodendrocytes in uninjured and injured tissue in the confocal microscope (data not shown).
Microglia and peripheral macrophages are RGS7 positive following injury
Numerous intensely RGS7 positive cells appeared very close to the lesion, fewer cells were observed up to 2 mm away from the cavity in the injured tissue. As no antibody can distinguish between activated microglia and invaded peripheral macrophages, we used two different antibodies to distinguish the morphology of these immunocompetent cells. The OX-42 antibody recognizes complement CD 11 (C3b receptor) expressed by resting and activated resident microglia as well as peripheral macrophages (Carlson et al., 1998) . ED-1 recognizes an intracellular antigen in activated microglia and macrophages. Resting microglia could be recognized by the distinct star-shape morphology, particularly with the OX-42 antibody. Activated phagocytic microglia are rounded and are therefore not easily distinguishable from peripheral macrophages (Carlson et al., 1998) . In contrast to the ED-1 antibody, the OX-42 antibody stains also resting microglia; both antibodies stain activated and phagocytic microglia and peripheral macrophages (Streit et al., 1988) .
In uninjured tissue, very few OX-42 positive cells were present and no ED-1 positive cells could be found. However after SCI, there were numerous, strongly OX-42 positive microglia with a rami®ed starshaped morphology in the grey and white matter close to the lesion epicentre. Beginning at day 1, however, more pronounced at day 3, these activated microglia changed their originally stellate morphology to a more rounded appearance. At day 3, some very intense RGS7 positive cells appeared and colocalized with OX-42 and ED-1 positive cells; however, only a subpopulation of these immunocompetent cells stained for RGS7 (Fig. 4A±C and E±G) The colocalization was mainly observed in active phagocytic cells with a more round morphology, some of them also had intracellular lipid accumulation. However, some of the star-shaped OX-42 and stellate shaped ED-1 positive cells did also colocalize with RGS7. At day 7, the number of ED-1 positive cells increased dramatically, most of them with the round morphology. Peripheral macrophages in the spleen are RGS7 positive
In the spleen, OX-42 and ED-1 positive immune competent cells were mainly localized in the perinodular rim, whereas RGS7 positive cells were also seen in the matrix between the nodules, but not in the nodules itself. As in the spinal cord, RGS7 appeared in a granular form within the cytoplasm. The majority of RGS7 positive cells do colocalize with either OX-42 or ED-1 (Fig. 4D and H) .
In vitro determination of RGS7 and Gb 5 expression in microglia/macrophages
As previous studies of RGS7 and Gb 5 did not detect these molecules in non-neuronal tissues and cell lines (Watson et al., 1994; Liang et al., 2000; Witherow et al., 2000; Zhang et al., 2001) , detection on RGS7 in activated microglia and peripheral macrophages was unexpected. We used a combination of immunocytochemistry, Western blotting, immunoprecipitation, and mRNA analysis to assess in vitro RGS7 and Gb 5 expression in microglia and macrophages cell lines.
As a positive control rat PC12 pheochromocytoma were stained for RGS7 as they are known to express RGS7 (Zhang et al., 2001 ). Similar to the epi¯uorescence staining pattern, confocal image analysis revealed a granular pattern of the cytoplasm and the nuclear membrane. The nucleus and the nucleolus were only weakly RGS7 positive, similar to a recent report of describing a strong cytoplasmatic and a fainter as well as less consistent nuclear staining pattern in PC12 cells (Zhang et al., 2001) (Fig. 5A) .
To con®rm the speci®city of immunocytochemistry using the anti-RGS7 antibody, wells with HEK 293 cells were randomly transfected with RGS7. As transfection marker, green¯uorescent protein was used. After ®xation, the cells were stained for RGS7. In an unbiased, blinded evaluation, all wells containing RGS7 transfected cells were recognized (Fig. 5B) .
RGS7 expression in microglia/macrophages was con®rmed in vitro with immunocytochemistry of RAW and BV2 cells. Non-stimulated RAW stained for RGS7 and Gb 5 . Following LPS and TNF-a (data not shown) stimulation for 48 h the number of positively RGS7 and Gb 5 stained cells remained stable (Fig. 5C and D) . The staining pattern of Gb 5 was more homogeneous compared to the granular RGS7 staining pattern. Intracytoplasmic vacuoles were observed in some cells similar to the in vivo ®ndings of phagocytotic in¯amma-tory cells. Immunocytochemistry of BV2 cells also revealed the presence of RGS7 and Gb 5 in microglia. Naõ Ève BV2 cells positively stained for RGS7. However, 48 h following LPS or TNF-a stimulation, the number of RGS7 positive cells increased approximately 3-fold and the cells enlarged by a factor of 1.5. In LPS stimulated BV2 cells RGS7 staining was seen consistently in a very distinct granular matter in the cytoplasm, whereas only a faint nuclear staining pattern was observed ( Fig. 5E and F) . Non-stimulated BV2 cells stained weaker for Gb 5 compared to RGS7. Following 48 h of LPS or TNF-a stimulation, the number of Gb 5 positive cells increased approximately 2-fold. The cytoplasmatic staining pattern for Gb 5 was more homogenous in contrast to the granular RGS7 staining pattern and the intensity of the nuclear staining pattern was increased compared to the RGS7 labelling.
To con®rm the results of the in vitro immunocytochemistry, Western blots and immunoprecipitation of RAW cell were performed. Western blotting demonstrated that non-stimulated RAW cells had distinct RGS7 and Gb 5 bands. The RGS7 bands were blocked completely with RGS7 peptide. Peak expression of RGS7 was found 48 h after LPS stimulation, whereas the Gb 5 band remained stable following LPS stimulation (data not shown). To con®rm that RGS7 and Gb 5 in RAW cells form a dimer, we immunoprecipitated cell lysates with RGS7 speci®c antibody and probed the immunoprecipitants with Gb 5 antibody. The results shown in Fig. 6 demonstrate that Gb 5 is tightly associated with RGS7 in a complex that is similar to one detected in the brain (Witherow et al., 2000; Zhang et al., 2000) .
The presence of RGS7 mRNA in peripheral macrophages was con®rmed with RT-PCR in LPS or TNF-a stimulated RAW cells (Fig. 7) . However, we could not detect RGS7 mRNA in naõ Ève nonstimulated cells.
Discussion
This study is the ®rst to demonstrate the up-regulated RGS7 expression and expression of the RGS7-Gb 5 complex following SCI in activated microglia and peripheral macrophages. This ®nding is supported by in vitro immunocytochemistry, Western blotting, and RT-PCR detection in microglia and peripheral macrophage cell lines. We also demonstrate that RGS7 and Gb 5 form a complex in macrophage cell lines. Furthermore, this study con®rms the previous reports of RGS7 expression in neurons ( concord with the responses of the immunocompetent cells. These data suggest, that SCI-induced up-regulation of RGS7 in immune cells contributes to the modulation of the post-traumatic in¯ammatory reaction within the CNS.
RGS7 staining pattern following SCI
An increased intensity of the RGS7 staining was observed following injury, both in the grey and white matter, primarily in the lesion area. We did not detect a quantitative increase of RGS7 and Gb 5 in Western blots in the solubilized fraction of injured compared to control spinal cord. These results may seem contradictory, but may be explained by the fact that the reduction of RGS7 due to neuronal cell death is replaced by an induction of RGS7 expression in microglia/ macrophages, as the time-course of the RGS7 up-regulation after SCI is in concord with responses of the immunocompetent cells. Another explanation is that for Western blot experiments a 1.8-mm long spinal cord segment was homogenized and therefore the up-regulation of RGS7 in immune cells after SCI could not be detected quantitatively due to dilution by uneffected tissue.
Very small RGS7 positive structures could be seen in the intercellular space, possibly representing receptor or synapses staining on the membrane surface of the neuronal processes. It is conceivable that neurons under injury-induced stress release RGS7 positive material (degranulation) causing the increase of granular staining in the extracellular space.
Neuro®lament positive axonal end bulbs which were found in the grey matter following injury may represent a secondary axotomy due to an axolemmal permeability change causing a focal swelling (Pettus & Povlishock, 1996) . These distinct axonal end bulbs did colocalize with RGS7.
In accordance with earlier studies (Zhang et al., 2001) , we also found that the nuclear staining pattern of Gb 5 is more intense compared to RGS7, suggesting that Gb 5 undergoes a nuclear translocation in neurons. The function of Gb 5 and RGS7 in the nucleus of neurons remains unknown (Zhang et al., 2001 ). At present the only known function of Gb 5 -RGS7 complex is to act as GAP for Ga subunits (Posner et al., 1999; Kovoor et al., 2000; Witherow et al., 2000; Keren-Raifman et al., 2001 ).
Gb 5 -RGS7 complex in microglia and macrophages
Microglia occupy approximately 13% of the entire glial cell population and are distributed diffusely throughout the whole CNS (Watanabe et al., 1999) . After SCI, microglia/macrophages strongly express RGS7, especially when they are located within the penumbra. As no antibody is able to distinguish activated microglia and peripheral macrophages (Carlson et al., 1998) , we con®rmed our in vivo ®ndings with in vitro study by immunocytochemistry, RT-PCR, and Western blotting, demonstrating expression of the RGS7-Gb 5 complex in both microglia (BV2) and peripheral macrophage (RAW) cell lines.
Further, RGS7 positive cells were seen in peripheral immune tissue, such as the spleen. While this departs from the current belief that RGS7 is solely expressed in the CNS along with Gb 5 , it should also be noted that Jones et al (1998) reported that human Gb 5 mRNA was also found in non-CNS tissue. Thus, while the current belief is that RGS7 and Gb 5 always exists together as a dimer in the CNS due to their rapid degradation when expressed alone (Witherow et al., 2000) , this ®nding suggests the dimer also exists in the peripheral immune tissue.
As microglia and peripheral macrophages both express injuryinduced RGS7, it is tempting to speculate that this supports the theory of the mesodermal origin of microglia in contrast to the neuroectodermal origin of other glia cells (astrocytes and oligodendrocytes) and neurons (Streit et al., 1988) .
Up-regulation mechanism
Numerous studies have shown that proin¯ammatory cytokines such as TNF-a are up-regulated after SCI (Bartholdi & Schwab, 1997; Bethea et al., 1999; Hayashi et al., 2000; Popovich, 2000; Taoka & Okajima, 2000) . Up-regulation of proin¯ammatory cytokines and chemokines are involved in the activation of microglia and the recruitment of peripheral macrophages. In mice lacking TNF-a receptors, reduced microglia activation was found following traumatic brain injury (Bruce et al., 1996) , suggesting that TNF-a plays an important role in microglia activation. TNF-a induced upregulation of RGS7 may contribute to trauma induced in¯ammatory alterations in the CNS. The effect of TNF-a prevented degradation of RGS7 on post-traumatic scar formation is as yet unknown. SCI results in a glial reaction, leading to scar formation in which axonal regeneration fails and remyelination is also unsuccessful (Schwab & Bartholdi, 1996; Fawcett & Asher, 1999) . Although the exact role of activated microglia/macrophages in scar formation after SCI is yet unclear, evidence suggests that microglia are likely to help CNS regeneration and that their presence in scar tissue is unlikely to contribute signi®cantly to its inhibitory nature (Fawcett & Asher, 1999) .
The RT-PCR studies show an increased expression of RGS7 mRNA following LPS and TNF-a challenge. A previous report showing TNF-a mediated up-regulation of RGS7 suggest that a phosphorylation event inhibits RGS7 degradation . Functional speci®city and temporal activity of RGS proteins depend on speci®c patterns of expression, transcriptional regulation, and subcellular localization. RGS7 protein levels are post-translationally regulated through rapid degradation by the ubiquitindependent proteasome pathway Kim et al., 1999) . However, little is known about the upstream and downstream regulation of RGS7.
Future studies will investigate what effect of blocking RGS7 has on in¯ammation following SCI.
